Hacker News15h ago530 points256 commentslive

Moderna reports first positive Phase 3 for mRNA neoantigen therapy in melanoma

Moderna and Merck announced positive Phase 3 results for intismeran autogene, an individualized mRNA therapy for melanoma, which met its primary endpoint of recurrence-free survival.

Read the full story attwitter.com

Why this is in the Signal

LAXIMA AI Signal curates the highest-velocity stories across Hacker News, GitHub trending, and new Hugging Face / Replicate model releases — quality-filtered, deduplicated, and refreshed every four hours. This item surfaced from Hacker News with 530 points (by heydenberk). We link straight to the original source above — see the full live feed.

More AI Signal briefs

Get the Signal